Nebraska Methodist Hospital Estabrook Cancer Center — Omaha, Nebraska

Nebraska Methodist Hospital Estabrook Cancer Center is a clinical research site located in Omaha, Nebraska, United States 68114.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Nebraska Methodist Hospital Estabrook Cancer Center has participated in 1 clinical trials.

Therapeutic areas: Metastatic Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Nebraska Methodist Hospital Estabrook Cancer Center?

Nebraska Methodist Hospital Estabrook Cancer Center has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Nebraska Methodist Hospital Estabrook Cancer Center conducted?

Nebraska Methodist Hospital Estabrook Cancer Center has 1 clinical trials on record. Their work covers Metastatic Breast Cancer.

Is Nebraska Methodist Hospital Estabrook Cancer Center accredited by Crixeo Health?

Nebraska Methodist Hospital Estabrook Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Nebraska Methodist Hospital Estabrook Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.